| scholarly article | Q13442814 |
| P50 | author | Patrizia Hrelia | Q43097748 |
| Giorgio Cantelli-Forti | Q43098665 | ||
| Andrea Pession | Q54643363 | ||
| P2093 | author name string | Roberto Tonelli | |
| Giorgio Cantelli-Forti | |||
| Cristina Nanni | |||
| Carmelo Quarta | |||
| Stefano Fanti | |||
| Elisa Bergantin | |||
| P2860 | cites work | Sulforaphane as a promising molecule for fighting cancer | Q56656827 |
| Safety, Tolerance, and Metabolism of Broccoli Sprout Glucosinolates and Isothiocyanates: A Clinical Phase I Study | Q63433163 | ||
| MYCN expression in human rhabdomyosarcoma cell lines and tumour samples | Q77839834 | ||
| The PAX3-FKHR fusion protein created by the t(2;13) translocation in alveolar rhabdomyosarcomas is a more potent transcriptional activator than PAX3 | Q24313754 | ||
| PAX3-FKHR and PAX7-FKHR gene fusions are prognostic indicators in alveolar rhabdomyosarcoma: a report from the children's oncology group | Q28201860 | ||
| Differential regulation of the TRAIL death receptors DR4 and DR5 by the signal recognition particle | Q33206588 | ||
| Reproducibility of 18F-FDG microPET studies in mouse tumor xenografts | Q34164724 | ||
| Sulforaphane Increases Drug-mediated Cytotoxicity Toward Cancer Stem-like Cells of Pancreas and Prostate | Q34473316 | ||
| Isothiocyanates as cancer chemopreventive agents: their biological activities and metabolism in rodents and humans | Q34706257 | ||
| Molecular pathogenesis of rhabdomyosarcoma | Q34779149 | ||
| TRAIL signaling and synergy mechanisms used in TRAIL-based combination therapies | Q37974875 | ||
| Sulforaphane inhibits histone deacetylase in vivo and suppresses tumorigenesis in Apc-minus mice | Q38268094 | ||
| Antitumor activity of sustained N-myc reduction in rhabdomyosarcomas and transcriptional block by antigene therapy | Q39446630 | ||
| p21 Downregulation is an important component of PAX3/FKHR oncogenicity and its reactivation by HDAC inhibitors enhances combination treatment. | Q39706036 | ||
| FDG small animal PET permits early detection of malignant cells in a xenograft murine model. | Q40198035 | ||
| Identification of a PAX-FKHR gene expression signature that defines molecular classes and determines the prognosis of alveolar rhabdomyosarcomas | Q40254065 | ||
| Inhibition of angiogenesis and endothelial cell functions are novel sulforaphane-mediated mechanisms in chemoprevention. | Q40302650 | ||
| Sulforaphane sensitizes tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-resistant hepatoma cells to TRAIL-induced apoptosis through reactive oxygen species-mediated up-regulation of DR5. | Q40321960 | ||
| Phase I dose-escalation study of recombinant human Apo2L/TRAIL, a dual proapoptotic receptor agonist, in patients with advanced cancer | Q40359028 | ||
| The dietary isothiocyanate sulforaphane targets pathways of apoptosis, cell cycle arrest, and oxidative stress in human pancreatic cancer cells and inhibits tumor growth in severe combined immunodeficient mice | Q40503935 | ||
| Sulforaphane induces caspase-mediated apoptosis in cultured PC-3 human prostate cancer cells and retards growth of PC-3 xenografts in vivo | Q40630814 | ||
| Nuclear factor kappa B is a molecular target for sulforaphane-mediated anti-inflammatory mechanisms. | Q40798546 | ||
| Validation of met as a therapeutic target in alveolar and embryonal rhabdomyosarcoma. | Q42802665 | ||
| Modulation of phase II enzymes by sulforaphane: implications for its cardioprotective potential | Q45014174 | ||
| P433 | issue | 9 | |
| P921 | main subject | rhabdomyosarcoma | Q1898141 |
| P304 | page(s) | 1219-1225 | |
| P577 | publication date | 2014-06-27 | |
| P1433 | published in | Cancer Biology and Therapy | Q2544651 |
| P1476 | title | Sulforaphane induces apoptosis in rhabdomyosarcoma and restores TRAIL-sensitivity in the aggressive alveolar subtype leading to tumor elimination in mice | |
| P478 | volume | 15 |
| Q37564708 | Alveolar rhabdomyosarcoma: morphoproteomics and personalized tumor graft testing further define the biology of PAX3-FKHR(FOXO1) subtype and provide targeted therapeutic options |
| Q58750953 | Chemopreventive activity of sulforaphane |
| Q39136514 | DNA Microarray Profiling Highlights Nrf2-Mediated Chemoprevention Targeted by Wasabi-Derived Isothiocyanates in HepG2 Cells |
| Q39045906 | Nrf2 targeting by sulforaphane: A potential therapy for cancer treatment |
| Q59807366 | Sulforaphane from Cruciferous Vegetables: Recent Advances to Improve Glioblastoma Treatment |
| Q36413327 | Sulforaphane inhibits thyroid cancer cell growth and invasiveness through the reactive oxygen species-dependent pathway |
| Q37330410 | Thapsigargin sensitizes human esophageal cancer to TRAIL-induced apoptosis via AMPK activation. |
| Q38780660 | The effects of sulforaphane on canine osteosarcoma proliferation and invasion. |
Search more.